0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover660.67%IV255.45%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.5513Delta0.1087Gamma2.81Leverage Ratio-0.0294Theta0.0003Rho1.55Eff Leverage0.0022Vega
Lexicon Pharmaceuticals Stock Discussion
Lexicon Pharmaceuticals Inc - Co Anticipates Six Month Review and Potential Launch in Early 2025
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has announced the publication of a research paper in the peer-reviewed Journal of the American College of Cardiology: Heart Failure, highlighting the cost-effectiveness of INPEFA® (sotagliflozin). This study is significant in the context of diabetes and recent worsening heart failure, concluding that INPEFA® i...
Medidata’s technology to improve patient experience, accelerate clinical trials, and streamline enrollment process
NEW YORK, May 29, 2024--(BUSINESS WIRE)--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced today that it has been selected by Lexicon Pharmaceuticals, Inc...
No comment yet